How big is the India Active Pharmaceutical Ingredients (API) Market?

The India Active Pharmaceutical Ingredients (API) Market size is expected to reach USD 13.64 billion in 2024 and grow at a CAGR of 8.31% to reach USD 20.32 billion by 2029. Read More

What is the current India Active Pharmaceutical Ingredients (API) Market size?

In 2024, the India Active Pharmaceutical Ingredients (API) Market size is expected to reach USD 13.64 billion. Read More

Who are the key players in India Active Pharmaceutical Ingredients (API) Market?

Aurobindo Pharma, Lupin Ltd, Viatris Inc., Sun Pharmaceutical Industries Ltd and Teva Pharmaceutical Industries Ltd are the major companies operating in the India Active Pharmaceutical Ingredients (API) Market. Read More

What years does this India Active Pharmaceutical Ingredients (API) Market cover, and what was the market size in 2023?

In 2023, the India Active Pharmaceutical Ingredients (API) Market size was estimated at USD 12.59 billion. The report covers the India Active Pharmaceutical Ingredients (API) Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the India Active Pharmaceutical Ingredients (API) Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

India Active Pharmaceutical Ingredients (API) Market Share

Statistics for the 2023 & 2024 India Active Pharmaceutical Ingredients (API) market share, created by Mordor Intelligence™ Industry Reports. India Active Pharmaceutical Ingredients (API) share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of India Active Pharmaceutical Ingredients (API) Industry

The Indian active pharmaceutical ingredients market is relatively fragmented. The API market has several manufacturers focusing on expanding their footprints by adopting various business strategies such as collaborations, facility expansion, and drug approvals. Some of the companies in the market are Aurobindo Pharma, Teva Pharmaceutical Industries Ltd, Lupin Ltd, Viatris Inc., Sun Pharmaceuticals Limited, and Dr. Reddy's Laboratories Ltd, among others.